Crispr Therapeutics shares owned by Bedell Investment Counselling
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bedell Investment Counselling
from 13F filings
Historical chart of Bedell Investment Counselling investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bedell Investment Counselling consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bedell Investment Counselling
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.1M | 25k | 45.39 |
| 2023-06-30 | $1.4M | 24k | 56.14 |
| 2023-03-31 | $1.2M | 27k | 45.23 |
| 2022-12-31 | $1.1M | 28k | 40.65 |
| 2022-09-30 | $2.1M | 32k | 65.34 |
| 2022-06-30 | $2.1M | 34k | 60.78 |
| 2022-03-31 | $1.9M | 30k | 62.75 |
| 2021-12-31 | $2.0M | 27k | 75.79 |
| 2021-09-30 | $2.8M | 25k | 111.94 |
| 2021-06-30 | $3.8M | 24k | 161.87 |
| 2021-03-31 | $2.8M | 23k | 121.83 |
| 2020-12-31 | $2.7M | 18k | 153.12 |
More positions owned by Bedell Investment Counselling
View all positions for Bedell Investment Counselling